Cipla: Difference between revisions
CSV import Tags: mobile edit mobile web edit |
CSV import |
||
| Line 1: | Line 1: | ||
{{short description|Indian multinational pharmaceutical company}} | |||
{{Use dmy dates|date=October 2023}} | |||
== | ==Cipla== | ||
[[ | [[File:Cipla_logo.svg|thumb|right|Cipla logo]] | ||
'''Cipla Limited''' is an Indian multinational pharmaceutical company, headquartered in [[Mumbai]], [[India]]. The company was founded in 1935 by [[Khwaja Abdul Hamied]] as "The Chemical, Industrial & Pharmaceutical Laboratories". Cipla is known for its pioneering efforts in the production of low-cost generic medications, particularly for the treatment of [[HIV/AIDS]]. | |||
== | ==History== | ||
Cipla was established in 1935 with the aim of producing affordable medicines for the Indian population. Over the decades, Cipla has grown into a global pharmaceutical company with a presence in over 80 countries. The company played a significant role in the fight against [[HIV/AIDS]] by providing affordable antiretroviral drugs to developing countries. | |||
== | ==Products and Services== | ||
Cipla manufactures a wide range of pharmaceutical products, including prescription drugs, over-the-counter medications, and active pharmaceutical ingredients (APIs). The company's product portfolio covers various therapeutic areas such as [[cardiology]], [[respiratory]], [[oncology]], [[diabetes]], and [[infectious diseases]]. | |||
== | ===Generic Medications=== | ||
Cipla is renowned for its production of generic medications, which are bioequivalent to branded drugs but are sold at a lower cost. This has made essential medicines more accessible to patients worldwide, particularly in low- and middle-income countries. | |||
== See | ===Research and Development=== | ||
Cipla invests significantly in [[research and development]] to innovate and improve its product offerings. The company focuses on developing new formulations and drug delivery systems to enhance patient compliance and therapeutic outcomes. | |||
==Global Presence== | |||
Cipla has a strong international presence, with manufacturing facilities and offices in various countries. The company exports its products to over 150 countries, with a significant market share in [[Africa]], [[Asia]], and [[Latin America]]. | |||
==Corporate Social Responsibility== | |||
Cipla is committed to corporate social responsibility (CSR) initiatives, focusing on healthcare, education, and environmental sustainability. The company has launched several programs to improve access to healthcare and support community development. | |||
==See also== | |||
* [[Pharmaceutical industry in India]] | * [[Pharmaceutical industry in India]] | ||
* [[ | * [[Generic drug]] | ||
* [[HIV/AIDS in India]] | |||
==Related pages== | |||
* [[Sun Pharmaceutical]] | |||
* [[Dr. Reddy's Laboratories]] | |||
* [[Lupin Limited]] | |||
[[Category:Pharmaceutical companies of India]] | [[Category:Pharmaceutical companies of India]] | ||
[[Category:Companies based in Mumbai]] | [[Category:Companies based in Mumbai]] | ||
[[Category:Companies established in 1935]] | [[Category:Companies established in 1935]] | ||
[[Category:Multinational companies headquartered in India]] | |||
Latest revision as of 03:43, 13 February 2025
Indian multinational pharmaceutical company
Cipla[edit]
Cipla Limited is an Indian multinational pharmaceutical company, headquartered in Mumbai, India. The company was founded in 1935 by Khwaja Abdul Hamied as "The Chemical, Industrial & Pharmaceutical Laboratories". Cipla is known for its pioneering efforts in the production of low-cost generic medications, particularly for the treatment of HIV/AIDS.
History[edit]
Cipla was established in 1935 with the aim of producing affordable medicines for the Indian population. Over the decades, Cipla has grown into a global pharmaceutical company with a presence in over 80 countries. The company played a significant role in the fight against HIV/AIDS by providing affordable antiretroviral drugs to developing countries.
Products and Services[edit]
Cipla manufactures a wide range of pharmaceutical products, including prescription drugs, over-the-counter medications, and active pharmaceutical ingredients (APIs). The company's product portfolio covers various therapeutic areas such as cardiology, respiratory, oncology, diabetes, and infectious diseases.
Generic Medications[edit]
Cipla is renowned for its production of generic medications, which are bioequivalent to branded drugs but are sold at a lower cost. This has made essential medicines more accessible to patients worldwide, particularly in low- and middle-income countries.
Research and Development[edit]
Cipla invests significantly in research and development to innovate and improve its product offerings. The company focuses on developing new formulations and drug delivery systems to enhance patient compliance and therapeutic outcomes.
Global Presence[edit]
Cipla has a strong international presence, with manufacturing facilities and offices in various countries. The company exports its products to over 150 countries, with a significant market share in Africa, Asia, and Latin America.
Corporate Social Responsibility[edit]
Cipla is committed to corporate social responsibility (CSR) initiatives, focusing on healthcare, education, and environmental sustainability. The company has launched several programs to improve access to healthcare and support community development.
